VKTX shares jump after early obesity-injection data optimism
Viking Therapeutics said early data for VK2735 (obesity injection) suggested most patients kept most weight off with every-other-week dosing or monthly dosing; Oppenheimer raised its target amid optimistic Wall Street commentary.